Form 4: Curis Inc. Director Martyn D. Greenacre Acquires Stock Options
Insider Transaction Report
Curis Inc. Director Martyn D. Greenacre was granted stock options for 6,800 shares of common stock.
Summary
- Martyn D. Greenacre, a Director at Curis Inc. (CRIS), was granted 6,800 non-qualified stock options.
- The options have an exercise price of $5.29 per share.
- The transaction date was July 7, 2026, with an expiration date of July 6, 2036.
- The options vest 100% on July 7, 2027.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine stock option grant to a director rather than significant financial results or strategic changes.
Positives
- Director Martyn D. Greenacre received a stock option grant, indicating potential alignment of management interests with shareholders.
- The stock options have a significant potential value if the company's stock price increases.
Risks
- The value of the stock options is contingent on the future performance of Curis Inc.'s stock price.
- There is a risk that the stock price may not appreciate sufficiently to make the options significantly valuable.
Future Outlook
The filing itself does not contain forward-looking statements or guidance regarding the company's financial performance. It solely reports a transaction related to executive compensation.
Industry Context
StockSavvy.ai notes that the issuance of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, like Curis Inc., to incentivize performance and align executive interests with long-term shareholder value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Martyn D. Greenacre has appointed attorneys-in-fact to execute Section 16 reporting forms on his behalf. | 04/24/2026 | Facilitates timely and accurate filing of required SEC disclosures by designated individuals. |
Stakeholder Impact
- Shareholders: The stock option grant aligns director incentives with potential stock price appreciation, which can benefit shareholders if the company performs well.
- Employees: This type of compensation for directors does not directly impact employees but reflects standard corporate governance practices.
Next Steps
- Martyn D. Greenacre may exercise these options if the stock price exceeds the exercise price of $5.29.
- The options will fully vest on July 7, 2027.
Key Dates
| Date | Description |
|---|---|
| 04/24/2026 | Date of execution of Power of Attorney by Martyn D. Greenacre. |
| 07/07/2026 | Transaction date for the grant of stock options. |
| 07/07/2027 | 100% vesting date for the granted stock options. |
| 07/06/2036 | Expiration date of the granted stock options. |
| 07/09/2026 | Date of signature for the Form 4 filing. |
Keywords
Curis Inc., CRIS, Form 4, Stock Options, Insider Trading, Director, SEC Filing, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.